SLP Quote, Financials, Valuation and Earnings

Schrodinger has a net margin of 1.09% compared to Simulations Plus's net margin of -108.07%. Simulations Plus's return on equity of 4.58% beat Schrodinger's return on equity of -34.83%.

Simulations Plus has a consensus price target of $49.00, signalling upside risk potential of 77.24%. On the other hand Schrodinger has an analysts' consensus of $32.00 which suggests that it could grow by 57.4%. Given that Simulations Plus has higher upside potential than Schrodinger, analysts believe Simulations Plus is more attractive than Schrodinger.

Simulations Plus has a beta of 0.797, which suggesting that the stock is 20.306% less volatile than S&P 500. In comparison Schrodinger has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Simulations Plus has a quarterly dividend of $0.06 per share corresponding to a yield of 0.85%. Schrodinger offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Simulations Plus pays 48.18% of its earnings as a dividend. Schrodinger pays out -- of its earnings as a dividend. Simulations Plus's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Simulations Plus quarterly revenues are $18.9M, which are smaller than Schrodinger quarterly revenues of $35.3M. Simulations Plus's net income of $206K is higher than Schrodinger's net income of -$38.1M. Notably, Simulations Plus's price-to-earnings ratio is 70.53x while Schrodinger's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Simulations Plus is 7.70x versus 7.70x for Schrodinger. Usually stocks with elevated PS ratios are considered overvalued.

Veeva Systems has a net margin of 1.09% compared to Simulations Plus's net margin of 26.57%. Simulations Plus's return on equity of 4.58% beat Veeva Systems's return on equity of 13.54%.

Simulations Plus has a consensus price target of $49.00, signalling upside risk potential of 77.24%. On the other hand Veeva Systems has an analysts' consensus of $269.16 which suggests that it could grow by 24.33%. Given that Simulations Plus has higher upside potential than Veeva Systems, analysts believe Simulations Plus is more attractive than Veeva Systems.

Simulations Plus has a beta of 0.797, which suggesting that the stock is 20.306% less volatile than S&P 500. In comparison Veeva Systems has a beta of 0.843, suggesting its less volatile than the S&P 500 by 15.729%.

Simulations Plus has a quarterly dividend of $0.06 per share corresponding to a yield of 0.85%. Veeva Systems offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Simulations Plus pays 48.18% of its earnings as a dividend. Veeva Systems pays out -- of its earnings as a dividend. Simulations Plus's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Simulations Plus quarterly revenues are $18.9M, which are smaller than Veeva Systems quarterly revenues of $699.2M. Simulations Plus's net income of $206K is lower than Veeva Systems's net income of $185.8M. Notably, Simulations Plus's price-to-earnings ratio is 70.53x while Veeva Systems's PE ratio is 53.65x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Simulations Plus is 7.70x versus 13.47x for Veeva Systems. Usually stocks with elevated PS ratios are considered overvalued.

Nano Mobile Healthcare has a net margin of 1.09% compared to Simulations Plus's net margin of --. Simulations Plus's return on equity of 4.58% beat Nano Mobile Healthcare's return on equity of --.

Simulations Plus has a consensus price target of $49.00, signalling upside risk potential of 77.24%. On the other hand Nano Mobile Healthcare has an analysts' consensus of -- which suggests that it could fall by --. Given that Simulations Plus has higher upside potential than Nano Mobile Healthcare, analysts believe Simulations Plus is more attractive than Nano Mobile Healthcare.

Simulations Plus has a beta of 0.797, which suggesting that the stock is 20.306% less volatile than S&P 500. In comparison Nano Mobile Healthcare has a beta of -0.274, suggesting its less volatile than the S&P 500 by 127.381%.

Simulations Plus has a quarterly dividend of $0.06 per share corresponding to a yield of 0.85%. Nano Mobile Healthcare offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Simulations Plus pays 48.18% of its earnings as a dividend. Nano Mobile Healthcare pays out -- of its earnings as a dividend. Simulations Plus's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Simulations Plus quarterly revenues are $18.9M, which are larger than Nano Mobile Healthcare quarterly revenues of --. Simulations Plus's net income of $206K is higher than Nano Mobile Healthcare's net income of --. Notably, Simulations Plus's price-to-earnings ratio is 70.53x while Nano Mobile Healthcare's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Simulations Plus is 7.70x versus -- for Nano Mobile Healthcare. Usually stocks with elevated PS ratios are considered overvalued.

Xsovt Brands has a net margin of 1.09% compared to Simulations Plus's net margin of --. Simulations Plus's return on equity of 4.58% beat Xsovt Brands's return on equity of --.

Simulations Plus has a consensus price target of $49.00, signalling upside risk potential of 77.24%. On the other hand Xsovt Brands has an analysts' consensus of -- which suggests that it could fall by --. Given that Simulations Plus has higher upside potential than Xsovt Brands, analysts believe Simulations Plus is more attractive than Xsovt Brands.

Simulations Plus has a beta of 0.797, which suggesting that the stock is 20.306% less volatile than S&P 500. In comparison Xsovt Brands has a beta of 5.728, suggesting its more volatile than the S&P 500 by 472.768%.

Simulations Plus has a quarterly dividend of $0.06 per share corresponding to a yield of 0.85%. Xsovt Brands offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Simulations Plus pays 48.18% of its earnings as a dividend. Xsovt Brands pays out -- of its earnings as a dividend. Simulations Plus's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Simulations Plus quarterly revenues are $18.9M, which are larger than Xsovt Brands quarterly revenues of --. Simulations Plus's net income of $206K is higher than Xsovt Brands's net income of --. Notably, Simulations Plus's price-to-earnings ratio is 70.53x while Xsovt Brands's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Simulations Plus is 7.70x versus -- for Xsovt Brands. Usually stocks with elevated PS ratios are considered overvalued.